Corrigendum to “IL-34 exacerbates pathogenic features of Alzheimers disease and calvaria osteolysis in triple transgenic (3x-Tg) female mice” [Biomed. Pharmacother. 166 (2023) 115435]
Year: 2026
Type: erratum
Abstract: This Corrigendum relates to the above article. Post-publication, an investigation identified a concern around the authenticity of the following figures/image panels: -Fig. 2C Panel Male Control and Fig. 2C Panel Male IL-34 appear to depict the same source image but are described as representing different experimental samples. Fig. 2C Panel Male Control and Fig. 2C Panel Male IL-34 appear to depict the same source image but are described as representing different experimental samples. The authors were requested to provide comments on these concerns, as well as the original unprocessed image files, to aid in the investigation. The authors have clarified that the images were inadvertently duplicated because an incorrect file was uploaded during the submission. The authors have provided the correct Fig. 2 and the legend as below. Unfortunately, this error was not identified at the time of publication. The authors regret any inconvenience this may have caused. Additionally, the investigation found that the authors do not report the complete and explicit approval number in their article regarding ethical approval for this publication, as required by the journal's policies. The authors sincerely apologise for not providing the ethical approval protocol numbers from the published manuscript and confirm that the study was conducted in strict accordance with the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The authors have provided supporting documents that the study was approved by the Institutional Animal Care and Use Committee of Nova Southeastern University and Indiana University School of Medicine. The original version of the ethical approval statement read as follows: "This study was conducted in strict accordance with the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All experimental procedures were approved by the Institutional Animal Care and Use Committee at Nova Southeastern University and Indiana University School of Medicine." The correct version of the ethical approval statement should be: "All experimental procedures were approved by the Institutional Animal Care and Use Committee at Nova Southeastern University (2019.01.AM3) and Indiana University School of Medicine (22036 MD/R/HZ)." This correction is intended to restore the true representation of the data and does not alter the overall scientific conclusions of the paper. The authors apologises for this oversight. The journal apologises that the oversight was not identified prior to publication.
Source: Biomedicine & Pharmacotherapy
Language: English
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,610
OpenAlex ID: W7149447214